ArticleHematology. American Society of Hematology. Education Program2025
Maintenance after CAR T? Are we there yet? Reducing the risk of relapse after loss of anti-CD19 CAR T-cell persistence in ALL.
Maria Gabelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.